Francesco Cognetti

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

David Grimes, Dominique Maraninchi, Ana Lluch, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate.

Angela Ferrari, F. Cognetti, C. Catricalà, 2006, Anticancer research.

HER2 and response to paclitaxel in node-positive breast cancer.

F. Cognetti, Francesco Cognetti, Gianluigi Ferretti, 2008, The New England journal of medicine.

KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting

L. Mantovani, N. Normanno, L. Capussotti, 2014, PloS one.

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Emilio Bria, Antonello Vidiri, Stefano Telera, 2011, Journal of experimental & clinical cancer research : CR.

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

Fiorella Guadagni, Patrizia Ferroni, Mario Roselli, 2001, Breast Cancer Research and Treatment.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Jacques Bernier, Michel Bolla, Mahmut Ozsahin, 2004, The New England journal of medicine.

Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases.

F. Cognetti, V. Ferraresi, Francesco Cognetti, 2005, Melanoma research.

Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.

Paolo Carlini, S. Di Cosimo, F. Cognetti, 2003, Drugs of today.